Correlation Between Summit Therapeutics and 04685A3F6

Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and 04685A3F6 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and 04685A3F6 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Summit Therapeutics PLC and ATH 1716 07 JAN 25, you can compare the effects of market volatilities on Summit Therapeutics and 04685A3F6 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of 04685A3F6. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and 04685A3F6.

Diversification Opportunities for Summit Therapeutics and 04685A3F6

-0.52

Correlation Coefficient

Summit Therapeutics  04685A3F6

Excellent diversification

The 3 months correlation between Summit and 04685A3F6 is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and ATH 1716 07 JAN 25 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATH 1716 07 and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with 04685A3F6. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATH 1716 07 has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and 04685A3F6 go up and down completely randomly.

Pair Corralation between Summit Therapeutics and 04685A3F6

Given the investment horizon of 90 days Summit Therapeutics PLC is expected to generate 1.31 times more return on investment than 04685A3F6. However, Summit Therapeutics is 1.31 times more volatile than ATH 1716 07 JAN 25. It trades about 0.22 of its potential returns per unit of risk. ATH 1716 07 JAN 25 is currently generating about -0.41 per unit of risk. If you would invest  1,928  in Summit Therapeutics PLC on October 27, 2024 and sell it today you would earn a total of  448.00  from holding Summit Therapeutics PLC or generate 23.24% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	21.05%
Values	Daily Returns

Summit Therapeutics PLC  vs.  ATH 1716 07 JAN 25

Summit Therapeutics PLC

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Summit Therapeutics PLC are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak primary indicators, Summit Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

ATH 1716 07

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ATH 1716 07 JAN 25 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for ATH 1716 07 JAN 25 investors.

Pair Trading with Summit Therapeutics and 04685A3F6

The main advantage of trading using opposite Summit Therapeutics and 04685A3F6 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, 04685A3F6 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 04685A3F6 will offset losses from the drop in 04685A3F6's long position.

The idea behind Summit Therapeutics PLC and ATH 1716 07 JAN 25 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.